Major Shareholders

Summary of Issued Securities 

Ordinary Shares

 
Issued Shares at 31 December 2016 318,706,844
Employee options over ordinary shares at 31 December 2016 10,725,250

Major Shareholders 
The top 20 Shareholders in Pharmaxis Ltd on 31 December 2016 are:

Name Number Of Shares % Total 
1. Citicorp Nominees Pty Limited 101,793,359 31.9%
2. National Nominees Limited 24,347,159 7.6%
3. HSBC Custody Nomiees (Australia) Limited  23,415,687  7.4%
4. JP Morgan Nominees Australia Limited 14,489,191 4.6%
5. TJ Huynh Pty Ltd 4,000,000 1.3%
6. Moggs Creek Pty Ltd 2,796,091 0.9%
7. George Engineering Pty Ltd (PG Super Fund) 2,500,000 0.8%
8. Healthcare Management Consulting (Australia) Pty Ltd 2,220,000 0.7%
9. Pakasoluto Pty Limited (Barkl Family Super Fund A/C) 2,086,838 0.7%
10. Simgon Pty Ltd 1,750,000 0.6%
11. Nr Yingkai Li 1,650,000 0.5%
12. Alpha Matilda Trading Pty Ltd 1,501,917 0.5%
13. David Newnham Super Pty Ltd 1,500,000 0.5%
14. Mr Marco Andrea Negro  1,200,000 0.4% 
15. Ginga Pty Ltd (TG Klinger S/F a/c) 1,159,397 0.4%
16. Mr Brian Tully & Mrs Margaret Tully 1,145,500 0.4%
17. Mutual Trust Pty Ltd 1,135,000 0.4%
18. Killcare Holdings Pty Ltd 1,104,413 0.4%
19. Capital Regional et Cooperatif Desjardins 1,053,867 0.3%
20. Brecus Pty Ltd (Brecus Super Fund a/c) 1,000,000 0.3%

Note: the above tables are updated after each quarter end

Substantial Shareholders 
Pharmaxis has received the following substantial shareholder notices: 

Name Percent Date 
Orbis Global Equity Fund Ltd 17.02% 27 September 2016
BVF Partners LP 12.99% 10 September 2015
Montoya Investments Limited 6.20% 12 April 2013
Australian Ethical Australian Share Fund 6.05% 3 February 2017